Meclizine Hydrochloride (meclizine) NDC 23155-943

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-943Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0943Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-943-01	23155094301	100 TABLET in 1 BOTTLE (23155-943-01)Marketed from Jun 25, 2026
23155-943-10	23155094310	1000 TABLET in 1 PACKAGE (23155-943-10)Marketed from Jun 25, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meclizine Hydrochloride
Generic name (nonproprietary): meclizine
Active ingredients: Meclizine hydrochloride — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205136
Marketing start: Jun 25, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Emesis Suppression (Physiologic effect)
Identifiers: Product ID 23155-943_eb857fbb-87f5-41dc-941a-21f6fb8df1e9SPL ID eb857fbb-87f5-41dc-941a-21f6fb8df1e9SPL set ID b11c10b9-f40e-4ea7-9c5d-118517049f9dRxCUI 995686UNII HDP7W44CIOUPC 0323155943016, 0323155943108
Pharmacologic class: Antiemetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155094301 followed by a unit qualifier and the quantity

Package 23155-0943-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 25, 2026.

Indications (excerpt from the label)

Meclizine hydrochloride tablets, USP are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride tablets, USP are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults (1).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)